BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 2871497)

  • 1. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Brenner AS; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):156-62. PubMed ID: 2871497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Illes P
    J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.
    Fuder H; Buder M; Riers HD; Rothacher G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):148-55. PubMed ID: 2871496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic inhibitory opioid delta- and kappa-receptors in a branch of the rabbit ileocolic artery.
    Von Kügelgen I; Illes P; Wolf D; Starke K
    Eur J Pharmacol; 1985 Nov; 118(1-2):97-105. PubMed ID: 2867914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.
    Giuliani S; Lecci A; Tramontana M; Maggi CA
    Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mu, delta, kappa and epsilon opioid receptor agonists on heart rate and blood pressure of the pithed rat.
    Eimerl J; Feuerstein G
    Neuropeptides; 1986; 8(4):351-8. PubMed ID: 2881224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors.
    Mulder AH; Hogenboom F; Wardeh G; Schoffelmeer AN
    J Neurochem; 1987 Apr; 48(4):1043-7. PubMed ID: 3029324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic opioid receptors in the portal vein of the rabbit.
    Szabo B; Wichmann T; Starke K
    Eur J Pharmacol; 1987 Jul; 139(1):103-10. PubMed ID: 2820753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of opioid receptor types modulating acetylcholine release in septal regions of the rat brain.
    Gazyakan E; Hennegriff M; Haaf A; Landwehrmeyer GB; Feuerstein TJ; Jackisch R
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):32-40. PubMed ID: 10935530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
    Mantelli L; Amerini S; Rubino A; Ledda F
    Eur J Pharmacol; 1990 May; 180(2-3):325-30. PubMed ID: 1973118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
    Bicknell RJ; Chapman C; Leng G
    Neuroendocrinology; 1985 Aug; 41(2):142-8. PubMed ID: 2864649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.